Marksans Pharma Ltd MARKSANS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 166.85
- Day Range
- INR 161.00–171.25
- 52-Week Range
- INR 70.55–185.50
- Bid/Ask
- INR 166.85 / INR 166.95
- Market Cap
- INR 75.61 Bil
- Volume/Avg
- 415,236 / 1.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 21.71
- Price/Sales
- 3.63
- Dividend Yield (Trailing)
- 0.30%
- Dividend Yield (Forward)
- 0.30%
- Total Yield
- 0.42%
Company Profile
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 852
- Website
- http://www.marksanspharma.com
Comparables
Valuation
|
Metric
|
MARKSANS
|
524348
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.71 | 26.49 | 24.76 |
Price/Book Value | 4.03 | 3.52 | 4.02 |
Price/Sales | 3.63 | 1.78 | 5.56 |
Price/Cash Flow | 19.28 | 20.04 | 28.27 |
Price/Earnings
MARKSANS
524348
543434
Financial Strength
|
Metric
|
MARKSANS
|
524348
|
543434
|
|---|---|---|---|
Quick Ratio | 3.37 | 0.91 | 3.14 |
Current Ratio | 5.12 | 1.66 | 6.26 |
Interest Coverage | 77.64 | 8.03 | 192.48 |
Quick Ratio
MARKSANS
524348
543434
Profitability
|
Metric
|
MARKSANS
|
524348
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.10% | — |
Return on Equity (Normalized) | — | 13.89% | — |
Return on Invested Capital (Normalized) | — | 10.74% | — |
Return on Assets
MARKSANS
524348
543434
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Hxdrmcyl | Bdjl | $732.9 Bil | |
JNJ
| Johnson & Johnson | Vxkxqckvx | Qnpnr | $372.2 Bil | |
MRK
| Merck & Co Inc | Vxxxlbtp | Rkfc | $332.3 Bil | |
ABBV
| AbbVie Inc | Bzcmykdb | Qvf | $290.2 Bil | |
AZN
| AstraZeneca PLC ADR | Vwqcmdhrrl | Pqbcp | $237.9 Bil | |
RHHBY
| Roche Holding AG ADR | Btwcxmcqm | Zzyx | $211.1 Bil | |
NVS
| Novartis AG ADR | Sqnwrddl | Xmm | $210.2 Bil | |
AMGN
| Amgen Inc | Wwtdgcmhsh | Xrd | $167.6 Bil | |
PFE
| Pfizer Inc | Bdhnwjsm | Ddt | $162.3 Bil | |
SNY
| Sanofi SA ADR | Yzgqnnd | Pjp | $121.1 Bil |